Use of new molecular tests for melanoma by pigmented-lesion experts
نویسندگان
چکیده
منابع مشابه
A large pigmented lesion mimicking malignant melanoma.
An 88-year-old woman was admitted with a huge bilateral pulmonary embolism and acute renal failure. On physical examination, a well-defined irregularly pigmented plaque 20 · 40 mm with black, brown and pink hues and an irregular border was noticed over the umbilicus (Fig. 1). A clinical diagnosis of malignant melanoma (MM) was suggested, and surgical excision planned. However, the patient’s pro...
متن کاملAn atypical pigmented lesion
BACKGROUND The dermatoscopic features of facial lentigo maligna (LM), facial lentigo maligna melanoma (LMM) and acral lentiginous melanoma (ALM) have been well described. This is the first description of the dermatoscopic appearance of a clinical series of cutaneous non-facial non-acral lentiginous growth pattern melanomas. OBJECTIVE To describe the dermatoscopic features of a series of cutan...
متن کاملPigmented Lesion of Buccal Mucosa
Pigmented lesions are commonly found in the mouth. Such lesions represent a variety of clinical entities, ranging from physiologic changes to manifestation of systemic illness and malignant neoplasm. Diagnosis of such lesions requires a proper case history, extraoral and intraoral examination, and, in some cases, biopsy, aspiration cytology, and laboratory investigations. Here we present a case...
متن کاملthe use of appropriate madm model for ranking the vendors of mci equipments using fuzzy approach
abstract nowadays, the science of decision making has been paid to more attention due to the complexity of the problems of suppliers selection. as known, one of the efficient tools in economic and human resources development is the extension of communication networks in developing countries. so, the proper selection of suppliers of tc equipments is of concern very much. in this study, a ...
15 صفحه اولExperts wrestle with problems developing biomarkers, search for new tests.
Biomarkers have a variety of uses in preclinical development: screening for promising drugs, determining the dosing and scheduling of a drug, predicting the risk of developing disease, predicting a patient's chance of responding to a drug or of having an adverse reaction to a drug, or serving as surrogate endpoints in a trial. And many researchers argue that the proper identifi cation and valid...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of the American Academy of Dermatology
سال: 2020
ISSN: 0190-9622
DOI: 10.1016/j.jaad.2019.08.022